NO SAFETY CONCERNS OBSERVED WHEN THE ADJUVANTED RECOMBINANT ZOSTER VACCINE (RZV) AND THE COVID-19 MRNA-1273 BOOSTER WERE CO-ADMINISTERED IN ≥50-YEAR-OLDS

por Naficy, A., Pirrotta, P., Kuxhausen, A., Miller, J., Leav, B., Mwakingwe-Omari, A.
Publicado 2023